EBS: going to 16-20WHO just approved ACCAM2000 for mpox ! Although I bought it because of Narcan, this is GOOOD news. Waiting on EEE.Virus news. If this works also out we will be heading above 100
EBS trade ideas
Emergent BioSolutions | Chart & Forecast SummaryKey Indicators on Trade Set Up in General
1. Push Set Up
2. Range Set up
3. Break & Retest Set Up
Notes On Session - 60 Minutes Time Frame
# Emergent BioSolutions - Based in Gaithersburg, Maryland | USA
- Trend Line 1&2 | Exchange Of Context
- WXY | Wave X | Point Of Control
- Inverted Head & Shoulders | Directional Trend Based Bias
Active Sessions on Relevant Range & Elemented Probabilities;
London(Upwards) - NYC(Downwards)
Conclusion | Trade Plan Execution & Risk Management on Demand;
Overall Consensus | Neutral
OD's In America EBS has THE main stream Narcan that dominates the market. With increasing over doses though out America. Earnings could make this move like crazyyyyyyyy.
If it is not this earnings then it is next, this stock can pop 50-100% in one day. Its a scalp trade.
Emergent Bio: Clear LONGDidn't change much yesterday's data... It remains the only solution out of the lethality rates of current opioid crisis !!! Target above 30 . For most of us this is a once in a lifetime Opprtunity
EBS Base Breakout SetupHey everybody got my camera working for this trade idea. Here we have the ebs stock setting up for a breakout in an uptrend and we're hoping for a bullish continuation here. I describe my entry points my stop loss and my profit target one and the logic behind them and how to position your share count so you can manage your risk and prepare to lose as much or as little money that you want if the trade goes against you every decision in this trade has meaning and logic to it that pertains to the particular stock and the setup therefore you know why you are doing everything that you're doing when trading. Let me know if you have any questions or if this is new to you or if you need help setting it up or calculating how much money you should win or lose. The only issue with this stock is that it's not in the technology sector and it's not in the communication sector so it is not in the most high performing sector right now although the healthcare sector is performing pretty decently with financials as well.
EBS - June 24 Qullamaggie Breakout and Episodic PivotThis is part of a Qullamaggie Breakout and Episodic Pivot study I am currently conducting
Qulla Breakout & EP (Discretionary & Systematic) 🚀
Swing Trend Strategy focused on Breakouts based on repeated momentum and Episodic Pivots based on unexpected news/fundamentals that is not properly priced in. The entery requirements are always price consolidation and tightening
EBS a biotech company focused on vaccinesEBS is a small biotechnology company whose forte is the clean processing and manufacturing
facility that the FDA requires for certain bioprocessing to be certified for delivery of products
to end-user patients. It is not a research facility like the one in China that accidentally released
COVID and the global impact will be likely felt for another decade. EBS does depend on
federal support and income from contract work from vaccine manufacturers. There is
reasonable expectation or persistent and consistent revenues ongoing without fail unless
the FDA decertified the facilities. On the chart, EBS is in a flat bottom triangle on its base.
It is presently rising out of the triangle and towards the mean anchored VWAP It is just above
The POC line which functions as dynamic support in the demand zone. I see a long trade
with the stop loss below the POC line, the first target the blue line representing one standard
deviation above the mean VWAP at about 9.4 while the second target is the redline two
standard deviations above the mean VWAP at about 10.05 while the final target contemplates
that EBS will challenge the high in May of 10.75.
$EBS - Narcan over the counter nose spray & Earnings 2/27I usually stray away from bio/biotech b/c of how volatile it is, but $EBS seems to be established with a $800M+ market cap, strong historicals, 20 PE ratio, and seems to be getting close to bottom. They also have an exciting narcan nasal spray product that can be sold over the counter they are working on releasing in 2023. Very relevant with all the overdoses going on in the US.
What do you guys think?
EBS long 12.00-9.00$The price is approaching the strong level of $10.60, and there is already increased interest in this stock. This stock has been showing growth in December for many years, so it makes sense to consider buying in the $12.00-9.00 area, stop-loss at $8.5. The first target is $25, the second target is $35.
Is EBS a buy as it hits a critical support level? EBS is currently hitting a critical support level around the 25 levels, which has been tested multiple times as key support and resistance level since 2009.
I am planning on buying at this current level, with a very high-profit target and a tight 5% stop loss below the support level. The ATH is over 400% above the current price, so there's a lot of upside potential in this trade, but it will need to be managed carefully since the market is in a downtrend right now.
EBS: It's pretty bad when you underperform TNXPConsidering TNXP does... well... nothing, EBS underperforming TNXP is disappointing. Still holding and will continue to buy shares if SP falls back into the gray area at $25-$32. Monthly hammer + continuation off a high volume node + 2.618 fib should indicate a trend reversal.
EBS was never a "squeeze" play because it's already worth a billion dollars. Additionally, I don't believe monkey pox is a serious pandemic regardless of what WHO says. EBS still has a pipeline of drugs that generates revenue and profit. With or without Monkey Pox, EBS should see $50-$60 (fibs) imo.
EBS: FEAR THE MONKEYPOX!Apparently, there will be a WHO meeting next meeting concerning how serious Monkey Pox is going to be. Potential Long Term Head and Shoulders forming. $25 is a long term support level and Monthly VPOC. Speculative trade back to the 200W MA at $60
EBS - Monkey pox is here Monkeypox has begun to expand. Vaccination is likely to increase in the coming months and this could lead to higher levels of shares of companies that produce vaccines.
EBS - Head and Shoulders Pattern, Weekly1/1 line is a major Trend line
Using the Fib circles the H&S pattern becomes more evident with the LS being rejected at the 1 level
The H being formed at 1.618
and the RS being formed in the aftermath of the H formation
I expect more downsides on this weekly timeframe until the strong support level is reached, which coincides also with the 1/2 Gann level
EBS ScalpJust broke trend, but long-term support below. I expect it to bounce and backtest the old trend, but no clue after. Could fall to $40 fib then maybe lower.
I love this as a long at some point though. Company got bad press and missed a COVID vaccine delivery after a factory was shut down. It's open now though and they still have a huge backlog of business and 4 years of revenue growth.
EBS LONGEBS broke the bear trend. Always when I saw such interception of MA lines, there was a huge growth. Now white candle (D) fixed above MA 50 and EMA 14, resistance broke. All point to growth.
EBS possible setup with 2 major supports EBS looks like a solid buy, I am investing at current price, if it goes down then I will add around second support.
Reasons to buy:
RSI looks oversold
Stock trading at long term trendline
2021 consensus earning estimate 9.01 which means 7~ PE.
Volume is increasing which shows it is getting attention
Once the FDA will approve its facility, it will fly. Also, even if it breaks current level 2nd huge support level is not that far. So, doesn't have much to loose.
$EBS Chart - Support, Resistance and TrendlineThree support and Three resistance drawn on daily chart. Trend reversal on daily chart. Need to look the chart again after one week
EBSClassic Bullish divergence on both the 4hr and daily timeframe.
Price has formed a descending wedge pattern and looks to have broken out.
Support has been found at the 0.886 fibonacci retracement level which is also a historical daily resistance level before running to ATH.
Pull Back Fishing Falling WedgeBullish engulfing candle today.
The .886 fib level may have been the landing pad, but the bottom is not always the bottom.
Biotech has been up and down so I am approaching this sector with caution for now. I have noted some biotech making daily or every other day yearly low and EBS made a new low yesterday and today although the 2 lows almost matched 58.79 today and 58.83 yesterday.
Negative volume is high. Short interest is 7.2%
Possible bullish divergence on RSI.
No recommendation
